Tharimmune to launch $540M Canton Coin treasury in funding led by DRW, Liberty City Ventures

Tharimmune, Inc. , a clinical-stage biotechnology company traditionally focused on developing therapies for rare immune, inflammatory, and oncologic diseases, has just announced its pivot into digital assets, raising approximately $540 million via a private placement led by proprietary trading firm DRW and crypto-focused venture capital firm Liberty City Ventures. According to Tharimmune, Inc. ’s announcement today, it […] source: https://www.cryptopolitan.com/tharimmune-540m-canton-coin-treasury/